These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

392 related items for PubMed ID: 24565972

  • 21. Novel amide and sulphonamide derivatives of 6-(piperazin-1-yl)phenanthridine as potent Mycobacterium tuberculosis H37Rv inhibitors.
    Naidu KM, Nagesh HN, Singh M, Sriram D, Yogeeswari P, Gowri Chandra Sekhar KV.
    Eur J Med Chem; 2015 Mar 06; 92():415-26. PubMed ID: 25590862
    [Abstract] [Full Text] [Related]

  • 22. Design, synthesis, biological evaluation of substituted benzofurans as DNA gyraseB inhibitors of Mycobacterium tuberculosis.
    Renuka J, Reddy KI, Srihari K, Jeankumar VU, Shravan M, Sridevi JP, Yogeeswari P, Babu KS, Sriram D.
    Bioorg Med Chem; 2014 Sep 01; 22(17):4924-34. PubMed ID: 25129171
    [Abstract] [Full Text] [Related]

  • 23. Functionalized 3-amino-imidazo[1,2-a]pyridines: a novel class of drug-like Mycobacterium tuberculosis glutamine synthetase inhibitors.
    Odell LR, Nilsson MT, Gising J, Lagerlund O, Muthas D, Nordqvist A, Karlén A, Larhed M.
    Bioorg Med Chem Lett; 2009 Aug 15; 19(16):4790-3. PubMed ID: 19560924
    [Abstract] [Full Text] [Related]

  • 24. Synthesis and antitubercular evaluation of novel dibenzo[b,d]thiophene tethered imidazo[1,2-a]pyridine-3-carboxamides.
    Pulipati L, Sridevi JP, Yogeeswari P, Sriram D, Kantevari S.
    Bioorg Med Chem Lett; 2016 Jul 01; 26(13):3135-3140. PubMed ID: 27184765
    [Abstract] [Full Text] [Related]

  • 25. The MM2QM tool for combining docking, molecular dynamics, molecular mechanics, and quantum mechanics.
    Nowosielski M, Hoffmann M, Kuron A, Korycka-Machala M, Dziadek J.
    J Comput Chem; 2013 Apr 05; 34(9):750-6. PubMed ID: 23233437
    [Abstract] [Full Text] [Related]

  • 26. Discovery of novel lysine ɛ-aminotransferase inhibitors: An intriguing potential target for latent tuberculosis.
    Devi PB, Sridevi JP, Kakan SS, Saxena S, Jeankumar VU, Soni V, Anantaraju HS, Yogeeswari P, Sriram D.
    Tuberculosis (Edinb); 2015 Dec 05; 95(6):786-794. PubMed ID: 26299907
    [Abstract] [Full Text] [Related]

  • 27. Design, chemical synthesis of 3-(9H-fluoren-9-yl)pyrrolidine-2,5-dione derivatives and biological activity against enoyl-ACP reductase (InhA) and Mycobacterium tuberculosis.
    Matviiuk T, Rodriguez F, Saffon N, Mallet-Ladeira S, Gorichko M, de Jesus Lopes Ribeiro AL, Pasca MR, Lherbet C, Voitenko Z, Baltas M.
    Eur J Med Chem; 2013 Dec 05; 70():37-48. PubMed ID: 24140915
    [Abstract] [Full Text] [Related]

  • 28. Design, synthesis and characterization of dual inhibitors against new targets FabG4 and HtdX of Mycobacterium tuberculosis.
    Banerjee DR, Biswas R, Das AK, Basak A.
    Eur J Med Chem; 2015 Jul 15; 100():223-34. PubMed ID: 26092447
    [Abstract] [Full Text] [Related]

  • 29. Rational design, synthesis and antitubercular evaluation of novel 2-(trifluoromethyl)phenothiazine-[1,2,3]triazole hybrids.
    Addla D, Jallapally A, Gurram D, Yogeeswari P, Sriram D, Kantevari S.
    Bioorg Med Chem Lett; 2014 Jan 01; 24(1):233-6. PubMed ID: 24314670
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. An efficient synthesis and biological screening of benzofuran and benzo[d]isothiazole derivatives for Mycobacterium tuberculosis DNA GyrB inhibition.
    Reddy KI, Srihari K, Renuka J, Sree KS, Chuppala A, Jeankumar VU, Sridevi JP, Babu KS, Yogeeswari P, Sriram D.
    Bioorg Med Chem; 2014 Dec 01; 22(23):6552-6563. PubMed ID: 25456076
    [Abstract] [Full Text] [Related]

  • 32. Novel ofloxacin derivatives: synthesis, antimycobacterial and toxicological evaluation.
    Dinakaran M, Senthilkumar P, Yogeeswari P, China A, Nagaraja V, Sriram D.
    Bioorg Med Chem Lett; 2008 Feb 01; 18(3):1229-36. PubMed ID: 18068979
    [Abstract] [Full Text] [Related]

  • 33. Design, synthesis and characterization of novel inhibitors against mycobacterial β-ketoacyl CoA reductase FabG4.
    Banerjee DR, Dutta D, Saha B, Bhattacharyya S, Senapati K, Das AK, Basak A.
    Org Biomol Chem; 2014 Jan 07; 12(1):73-85. PubMed ID: 24129589
    [Abstract] [Full Text] [Related]

  • 34. Inhibition of Mycobacterium tuberculosis pantothenate synthetase by analogues of the reaction intermediate.
    Ciulli A, Scott DE, Ando M, Reyes F, Saldanha SA, Tuck KL, Chirgadze DY, Blundell TL, Abell C.
    Chembiochem; 2008 Nov 03; 9(16):2606-11. PubMed ID: 18821554
    [No Abstract] [Full Text] [Related]

  • 35. Discovery of a Potent and Specific M. tuberculosis Leucyl-tRNA Synthetase Inhibitor: (S)-3-(Aminomethyl)-4-chloro-7-(2-hydroxyethoxy)benzo[c][1,2]oxaborol-1(3H)-ol (GSK656).
    Li X, Hernandez V, Rock FL, Choi W, Mak YSL, Mohan M, Mao W, Zhou Y, Easom EE, Plattner JJ, Zou W, Pérez-Herrán E, Giordano I, Mendoza-Losana A, Alemparte C, Rullas J, Angulo-Barturen I, Crouch S, Ortega F, Barros D, Alley MRK.
    J Med Chem; 2017 Oct 12; 60(19):8011-8026. PubMed ID: 28953378
    [Abstract] [Full Text] [Related]

  • 36. Design and synthesis of 11α-substituted bile acid derivatives as potential anti-tuberculosis agents.
    Pore VS, Divse JM, Charolkar CR, Nawale LU, Khedkar VM, Sarkar D.
    Bioorg Med Chem Lett; 2015 Oct 01; 25(19):4185-90. PubMed ID: 26299346
    [Abstract] [Full Text] [Related]

  • 37. Design, synthesis and anti-tubercular evaluation of new 2-acylated and 2-alkylated amino-5-(4-(benzyloxy)phenyl)thiophene-3-carboxylic acid derivatives. Part 1.
    Lu X, Wan B, Franzblau SG, You Q.
    Eur J Med Chem; 2011 Sep 01; 46(9):3551-63. PubMed ID: 21641695
    [Abstract] [Full Text] [Related]

  • 38. Identification of inhibitors targeting polyketide synthase 13 of Mycobacterium tuberculosis as antituberculosis drug leads.
    Wang X, Zhao W, Wang B, Ding W, Guo H, Zhao H, Meng J, Liu S, Lu Y, Liu Y, Zhang D.
    Bioorg Chem; 2021 Sep 01; 114():105110. PubMed ID: 34175719
    [Abstract] [Full Text] [Related]

  • 39. Synthesis, crystal structure and biological evaluation of substituted quinazolinone benzoates as novel antituberculosis agents targeting acetohydroxyacid synthase.
    Lu W, Baig IA, Sun HJ, Cui CJ, Guo R, Jung IP, Wang D, Dong M, Yoon MY, Wang JG.
    Eur J Med Chem; 2015 Apr 13; 94():298-305. PubMed ID: 25771108
    [Abstract] [Full Text] [Related]

  • 40. Discovery and development of novel salicylate synthase (MbtI) furanic inhibitors as antitubercular agents.
    Chiarelli LR, Mori M, Barlocco D, Beretta G, Gelain A, Pini E, Porcino M, Mori G, Stelitano G, Costantino L, Lapillo M, Bonanni D, Poli G, Tuccinardi T, Villa S, Meneghetti F.
    Eur J Med Chem; 2018 Jul 15; 155():754-763. PubMed ID: 29940465
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 20.